Compounds > 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin
Page last updated: 2024-09-03

1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Cardiac Failure

1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with Cardiac Failure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franco, R; Gavras, H; Gavras, I; Mulinari, RA; Wang, YX1

Other Studies

1 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Cardiac Failure

ArticleYear
Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction.
    Circulation, 1990, Volume: 81, Issue:1

    Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Diuresis; Heart Failure; Male; Rats; Rats, Inbred Strains; Ultrasonography; Vascular Resistance; Vasopressins

1990